{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:56:57Z","timestamp":1792540617897,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s13311-019-00805-5","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T19:03:42Z","timestamp":1573758222000},"page":"252-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor\/PI3K\/Akt\/BDNF Pathway in 3-Nitropropionic Acid Rat Model"],"prefix":"10.1016","volume":"17","author":[{"given":"Noha H.","family":"Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-7215","authenticated-orcid":false,"given":"Nevine","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"Kortam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed F.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1007\/s13311-019-00805-5_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"10.1007\/s13311-019-00805-5_bib2","series-title":"Huntington's disease: Clinical presentation and treatment","author":"Novak","year":"2011"},{"issue":"4","key":"10.1007\/s13311-019-00805-5_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/db12-1794","article-title":"DPP-4 Inhibition and Neuroprotection: Do Mechanisms Matter?","volume":"62","author":"Shannon","year":"2013","journal-title":"Diabetes."},{"key":"10.1007\/s13311-019-00805-5_bib4","doi-asserted-by":"crossref","unstructured":"Martin B, Golden E, Carlson OD, Pistell P, Zhou J, Kim W, et al. Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease. Diabetes.;58(2):318\u201328.","DOI":"10.2337\/db08-0799"},{"issue":"5","key":"10.1007\/s13311-019-00805-5_bib5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","article-title":"The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action","volume":"21","author":"Athauda","year":"2016","journal-title":"Drug Discov Today."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1673-5374.224365","article-title":"Tackling dipeptidyl peptidase IV in neurological disorders","volume":"13","author":"Al-Badri","year":"2018","journal-title":"Neural Regen Res."},{"issue":"8","key":"10.1007\/s13311-019-00805-5_bib7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1080\/1061186X.2018.1433682","article-title":"Possible role of DPP4 inhibitors to promote hippocampal neurogenesis in Alzheimer's disease","volume":"26","author":"Chalichem","year":"2018","journal-title":"J Drug Target."},{"key":"10.1007\/s13311-019-00805-5_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuropharm.2014.10.007","article-title":"Saxagliptin: A novel antiparkinsonian approach","volume":"89","author":"Nassar","year":"2015","journal-title":"Neuropharmacology."},{"issue":"6","key":"10.1007\/s13311-019-00805-5_bib9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2147\/VHRM.S3005","article-title":"Vildagliptin: a new oral treatment for type 2 diabetes mellitus","volume":"4","author":"Mathieu","year":"2008","journal-title":"Vasc Health Risk Manag."},{"issue":"3","key":"10.1007\/s13311-019-00805-5_bib10","first-page":"4113","article-title":"Vildagliptin prevents cognitive deficits and neuronal apoptosis in a rat model of Alzheimer's disease","volume":"17","author":"Ma","year":"2017","journal-title":"Mol Med Rep."},{"issue":"10","key":"10.1007\/s13311-019-00805-5_bib11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00210-018-1537-x","article-title":"Neuroprotective effect of vildagliptin against cerebral ischemia in rats","volume":"391","author":"El-Marasy","year":"2018","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"6","key":"10.1007\/s13311-019-00805-5_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2217\/fnl.12.72","article-title":"A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR","volume":"7","author":"Chong","year":"2012","journal-title":"Future Neurol."},{"issue":"2b","key":"10.1007\/s13311-019-00805-5_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","article-title":"Expression of Concern: Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington's Disease-like symptoms in rats: protective effect of licofelone","volume":"164","author":"Kumar","year":"2011","journal-title":"Br J Pharmacol."},{"issue":"6","key":"10.1007\/s13311-019-00805-5_bib14","first-page":"5100","article-title":"Vildagliptin, a DPP4 inhibitor, alleviates diabetes-associated cognitive deficits by decreasing the levels of apoptosis-related proteins in the rat hippocampus","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med."},{"issue":"2","key":"10.1007\/s13311-019-00805-5_bib15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/diabetes.54.2.554","article-title":"Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia\/reperfusion-induced myocardial injury","volume":"54","author":"Yue","year":"2005","journal-title":"Diabetes."},{"key":"10.1007\/s13311-019-00805-5_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcp.2018.01.047","article-title":"Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor\/PI3K\/Akt\/BDNF pathway and inhibition of angiotensin II type-1 receptor\/NF-\u03baB axis","volume":"151","author":"Rabie","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/toxsci\/kfq036","article-title":"A possible neuroprotective action of a vinylic telluride against Mn-induced neurotoxicity","volume":"115","author":"Avila","year":"2010","journal-title":"Toxicol Sci."},{"issue":"4","key":"10.1007\/s13311-019-00805-5_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod","volume":"20","author":"Jones","year":"1968","journal-title":"J Pharm Pharmacol."},{"issue":"6","key":"10.1007\/s13311-019-00805-5_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ijdevneu.2009.05.011","article-title":"Developmental omega-3 supplementation improves motor skills in juvenile-adult rats","volume":"27","author":"Coluccia","year":"2009","journal-title":"Int J Dev Neurosci."},{"issue":"1\u20132","key":"10.1007\/s13311-019-00805-5_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"ELLMAN","year":"1959","journal-title":"Arch Biochem Biophys."},{"issue":"4","key":"10.1007\/s13311-019-00805-5_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0197-4580(01)00226-3","article-title":"Effects of age and dietary antioxidants on cerebral electron transport chain activity","volume":"22","author":"Sharman","year":"2001","journal-title":"Neurobiol Aging."},{"issue":"6","key":"10.1007\/s13311-019-00805-5_bib24","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1007\/s12035-015-9303-2","article-title":"Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats","volume":"53","author":"Ahmed","year":"2016","journal-title":"Mol Neurobiol."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/exnr.1998.6926","article-title":"Striatal Transplantation in a Transgenic Mouse Model of Huntington's Disease","volume":"154","author":"Dunnett","year":"1998","journal-title":"Exp Neurol."},{"issue":"8","key":"10.1007\/s13311-019-00805-5_bib26","doi-asserted-by":"crossref","first-page":"a021691","DOI":"10.1101\/cshperspect.a021691","article-title":"The Striatum: Where Skills and Habits Meet","volume":"7","author":"Graybiel","year":"2015","journal-title":"Cold Spring Harb Perspect Biol."},{"issue":"9","key":"10.1007\/s13311-019-00805-5_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tics.2012.07.007","article-title":"Contributions of the striatum to learning, motivation, and performance: an associative account","volume":"16","author":"Liljeholm","year":"2012","journal-title":"Trends Cogn Sci."},{"issue":"2","key":"10.1007\/s13311-019-00805-5_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11011-016-9929-4","article-title":"Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats","volume":"32","author":"Suganya","year":"2017","journal-title":"Metab Brain Dis."},{"key":"10.1007\/s13311-019-00805-5_bib29","first-page":"1773","article-title":"Dubala A","volume":"65","author":"Kosaraju","year":"2013","journal-title":"Vildagliptin : an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer ' s disease."},{"issue":"5","key":"10.1007\/s13311-019-00805-5_bib30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jnc.13087","article-title":"Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NF\u03baB and Nrf2-antioxidant signaling pathways","volume":"133","author":"Abdelsalam","year":"2015","journal-title":"J Neurochem."},{"key":"10.1007\/s13311-019-00805-5_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2015.11.009","article-title":"ScienceDirect Effect of embelin against 3-nitropropionic acid-induced Huntington ' s disease in rats","volume":"77","author":"Dhadde","year":"2016","journal-title":"Biomed Pharmacother."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-27121-w","article-title":"Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6\/2 Mouse Model of Huntington's Disease","volume":"8","author":"Duarte","year":"2018","journal-title":"Sci Rep."},{"key":"10.1007\/s13311-019-00805-5_bib33","doi-asserted-by":"crossref","unstructured":"Foley JE, Jordan J. Weight neutrality with the DPP-4 inhibitor , vildagliptin : Mechanistic basis and clinical experience. Vasc Health Risk Manag. 2010;541\u20138.","DOI":"10.2147\/VHRM.S10952"},{"issue":"6","key":"10.1007\/s13311-019-00805-5_bib34","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.amjmed.2009.03.014","article-title":"Incretin Therapies : Effects Beyond Glycemic Control","volume":"122","author":"Mudaliar","year":"2009","journal-title":"Am J Med."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/db06-0565","article-title":"Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not","volume":"56","author":"Raun","year":"2007","journal-title":"Diabetes."},{"issue":"2","key":"10.1007\/s13311-019-00805-5_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1463-1326.2008.00994.x","article-title":"Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy","volume":"11","author":"Ferrannini","year":"2009","journal-title":"Diabetes, Obes Metab."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.diabres.2006.12.009","article-title":"Efficacy and tolerability of vildagliptin monotherapy in drug-na\u00efve patients with type 2 diabetes","volume":"76","author":"Pi-Sunyer","year":"2007","journal-title":"Diabetes Res Clin Pract."},{"issue":"10","key":"10.1007\/s13311-019-00805-5_bib38","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2174\/1389450111007011218","article-title":"Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease - from clinical features to the bench","volume":"11","author":"Rosenstock","year":"2010","journal-title":"Curr Drug Targets."},{"issue":"2","key":"10.1007\/s13311-019-00805-5_bib39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1463-1326.2006.00704.x","volume":"9","author":"Nauck","year":"2007","journal-title":"Diabetes, Obes Metab."},{"issue":"2","key":"10.1007\/s13311-019-00805-5_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tem.2013.10.006","article-title":"BDNF mediates adaptive brain and body responses to energetic challenges","volume":"25","author":"Marosi","year":"2014","journal-title":"Trends Endocrinol Metab."},{"key":"10.1007\/s13311-019-00805-5_bib41","series-title":"Neurotrophic factor therapy for Parkinson's disease","author":"Rangasamy","year":"2010"},{"issue":"1\u20133","key":"10.1007\/s13311-019-00805-5_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2009.12.023","article-title":"Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease","volume":"630","author":"McClean","year":"2010","journal-title":"Eur J Pharmacol."},{"key":"10.1007\/s13311-019-00805-5_bib43","first-page":"433","article-title":"Glucagon-Like Peptide-1 Analog, Liraglutide","volume":"7","author":"DellaValle","year":"2016","journal-title":"Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats. Front Pharmacol."},{"issue":"6","key":"10.1007\/s13311-019-00805-5_bib44","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1471-4159.2010.06731.x","article-title":"Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells","volume":"113","author":"Li","year":"2010","journal-title":"J Neurochem."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib45","doi-asserted-by":"crossref","first-page":"26859","DOI":"10.1038\/srep26859","article-title":"The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K\/AKT and MAPK Pathways","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci Rep."},{"key":"10.1007\/s13311-019-00805-5_bib46","first-page":"2653","article-title":"B DPPL, Medicine PLB, Hospital G. Minireview : Glucagon-Like Peptides Regulate Cell","volume":"145","author":"Drucker","year":"2015","journal-title":"Endocrinology."},{"issue":"4","key":"10.1007\/s13311-019-00805-5_bib47","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1210\/en.2002-220897","article-title":"Z DCX, Medical C. Glucagon-Like Peptide-1 Inhibits Apoptosis of Phosphatidylinositol 3-Kinase-Dependent Pathway","volume":"144","author":"Perfetti","year":"2003","journal-title":"Endocrinology."},{"issue":"2","key":"10.1007\/s13311-019-00805-5_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12640-016-9611-y","article-title":"Baicalin Attenuates Ketamine-Induced Neurotoxicity in the Developing Rats: Involvement of PI3K\/Akt and CREB\/BDNF\/Bcl-2 Pathways","volume":"30","author":"Zuo","year":"2016","journal-title":"Neurotox Res."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2008.05237.x","article-title":"BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation","volume":"105","author":"Hu","year":"2008","journal-title":"J Neurochem."},{"issue":"5","key":"10.1007\/s13311-019-00805-5_bib50","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/dneu.20765","article-title":"Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease","volume":"70","author":"Yoshii","year":"2010","journal-title":"Dev Neurobiol."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat Genet."},{"issue":"3","key":"10.1007\/s13311-019-00805-5_bib52","first-page":"4113","article-title":"Vildagliptin prevents cognitive deficits and neuronal apoptosis in a rat model of Alzheimer's disease","volume":"17","author":"Ma","year":"2018","journal-title":"Mol Med Rep."},{"issue":"5","key":"10.1007\/s13311-019-00805-5_bib53","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum Mol Genet."},{"issue":"17","key":"10.1007\/s13311-019-00805-5_bib54","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease","volume":"10","author":"Wyttenbach","year":"2001","journal-title":"Hum Mol Genet."},{"issue":"8","key":"10.1007\/s13311-019-00805-5_bib55","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hipo.22128","article-title":"PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model","volume":"23","author":"Giralt","year":"2013","journal-title":"Hippocampus."},{"issue":"3","key":"10.1007\/s13311-019-00805-5_bib56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1381612820666140826113957","article-title":"Phosphodiesterases as therapeutic targets for Huntington's disease","volume":"21","author":"Fusco","year":"2015","journal-title":"Curr Pharm Des."},{"issue":"3","key":"10.1007\/s13311-019-00805-5_bib57","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nbd.2009.02.014","article-title":"Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease","volume":"34","author":"Giamp\u00e0","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00805-5_bib58","doi-asserted-by":"crossref","unstructured":"Sa-nguanmoo P, Tanajak P, Kerdphoo S, Jaiwongkam T. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction , insulin resistance , in fl ammation , and apoptosis in HFD-induced obese rats. Toxicol Appl Pharmacol. 2017;333:43\u201350.","DOI":"10.1016\/j.taap.2017.08.005"},{"key":"10.1007\/s13311-019-00805-5_bib59","doi-asserted-by":"crossref","unstructured":"Takada S, Masaki Y, Kinugawa S, Matsumoto J, Furihata T, Mizushima W, et al. Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling. 2016;111:338\u201347.","DOI":"10.1093\/cvr\/cvw182"},{"issue":"4","key":"10.1007\/s13311-019-00805-5_bib60","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3892\/ijmm.2016.2503","article-title":"SIRT1 exerts protective effects against paraquat-induced injury in mouse type II alveolar epithelial cells by deacetylating NRF2 in vitro","volume":"37","author":"Ding","year":"2016","journal-title":"Int J Mol Med."},{"key":"10.1007\/s13311-019-00805-5_bib61","doi-asserted-by":"crossref","unstructured":"Satta S, Mahmoud AM, Wilkinson FL, Yvonne Alexander M, White SJ. The Role of Nrf2 in Cardiovascular Function and Disease. Oxid Med Cell Longev. 2017;1\u201318.","DOI":"10.1155\/2017\/9237263"},{"issue":"6","key":"10.1007\/s13311-019-00805-5_bib62","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yexcr.2017.09.042","article-title":"The crosstalk between Sirt1 and Keap1\/Nrf2\/ARE anti-oxidative pathway forms a positive feedback loop to inhibit FN and TGF-\u03b21 expressions in rat glomerular mesangial cells","volume":"361","author":"Huang","year":"2017","journal-title":"Exp Cell Res."},{"issue":"20","key":"10.1007\/s13311-019-00805-5_bib64","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1212\/WNL.0000000000003946","article-title":"Nrf2, cellular redox regulation, and neurologic implications","volume":"88","author":"Benarroch","year":"2017","journal-title":"Neurology [Internet]."},{"key":"10.1007\/s13311-019-00805-5_bib65","unstructured":"Hee S, Park S, Joo C, Leem J, Park K, Lee I. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation. Vascul Pharmacol. 2015;1\u20139."},{"key":"10.1007\/s13311-019-00805-5_bib66","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.intimp.2015.07.022","article-title":"International Immunopharmacology Amelioration of cyclosporine induced nephrotoxicity by dipeptidyl peptidase inhibitor vildagliptin","volume":"28","author":"Ateyya","year":"2015","journal-title":"Int Immunopharmacol."},{"issue":"5","key":"10.1007\/s13311-019-00805-5_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11910-015-0545-1","article-title":"Glutamate and GABA imbalance following traumatic brain injury","volume":"15","author":"Guerriero","year":"2015","journal-title":"Curr Neurol Neurosci Rep."},{"key":"10.1007\/s13311-019-00805-5_bib68","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1471-4159.2005.03047.x","article-title":"Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington ' s disease","volume":"93","author":"Pineda","year":"2005","journal-title":"J Neurochem."},{"issue":"47","key":"10.1007\/s13311-019-00805-5_bib69","doi-asserted-by":"crossref","first-page":"40464","DOI":"10.1074\/jbc.M111.232009","article-title":"Brain-derived Neurotrophic Factor (BDNF) Enhances GABA Transport by Modulating the Trafficking of GABA Transporter-1 (GAT-1) from the Plasma Membrane of Rat Cortical Astrocytes","volume":"286","author":"Vaz","year":"2011","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1007\/s13311-019-00805-5_bib70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/dbio.1994.1250","article-title":"Brain-Derived Neurotrophic Factor Promotes Differentiation of Striatal GABAergic Neurons","volume":"165","author":"Mizuno","year":"1994","journal-title":"Dev Biol."},{"issue":"5","key":"10.1007\/s13311-019-00805-5_bib71","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1046\/j.1471-4159.2000.0752190.x","article-title":"Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4\/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease","volume":"75","author":"P\u00e9rez-Navarro","year":"2000","journal-title":"J Neurochem."},{"issue":"7","key":"10.1007\/s13311-019-00805-5_bib72","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00125-015-3577-9","article-title":"Mitochondrial succinate dehydrogenase is involved in stimulus-secretion coupling and endogenous ROS formation in murine beta cells","volume":"58","author":"Edalat","year":"2015","journal-title":"Diabetologia."},{"issue":"8","key":"10.1007\/s13311-019-00805-5_bib73","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00125-005-1811-6","article-title":"Mitochondrial regulation of insulin production in rat pancreatic islets","volume":"48","author":"Leibowitz","year":"2005","journal-title":"Diabetologia."},{"key":"10.1007\/s13311-019-00805-5_bib74","doi-asserted-by":"crossref","unstructured":"Green CJ, Henriksen TI, Pedersen BK, Solomon TPJ. Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia. PLoS One. 2012;7(8).","DOI":"10.1371\/journal.pone.0044284"}],"updated-by":[{"DOI":"10.1007\/s13311-022-01227-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-019-00805-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923013958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T07:44:56Z","timestamp":1704181496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923013958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1878747923013958"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00805-5","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s13311-022-01227-6","asserted-by":"object"}]},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor\/PI3K\/Akt\/BDNF Pathway in 3-Nitropropionic Acid Rat Model","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00805-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01227-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}